Nixon Peabody Trust’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$370K Sell
890
-244
-22% -$90.4K 0.03% 144
2026
Q1
$307K Buy
1,134
+396
+54% +$118K 0.02% 134
2025
Q4
$244K Buy
+738
New +$250K 0.02% 148
2025
Q2
Sell
-536
Closed -$281K 156
2025
Q1
$281K Buy
536
+136
+34% +$69.5K 0.02% 137
2024
Q4
$202K Sell
400
-350
-47% -$199K 0.02% 144
2024
Q3
$439K Sell
750
-500
-40% -$283K 0.04% 105
2024
Q2
$637K Buy
1,250
+299
+31% +$147K 0.06% 85
2024
Q1
$470K Sell
951
-24
-2% -$12.2K 0.04% 93
2023
Q4
$513K Buy
975
+475
+95% +$253K 0.06% 82
2023
Q3
$252K Sell
500
-10
-2% -$4.92K 0.21% 70
2023
Q2
$245K Hold
510
0.2% 67
2023
Q1
$241K Sell
510
-10
-2% -$4.83K 0.17% 60
2022
Q4
$276K Buy
520
+10
+2% +$5.3K 0.22% 63
2022
Q3
$258K Sell
510
-230
-31% -$121K 0.22% 63
2022
Q2
$380K Sell
740
-176
-19% -$88.4K 0.17% 59
2022
Q1
$467K Sell
916
-111
-11% -$53.5K 0.16% 61
2021
Q4
$516K Buy
+1,027
New +$465K 0.16% 62

Other funds holding UNH

Nixon Peabody Trust's UNH Position: Q2 2026 in Review

Nixon Peabody Trust reduced its UnitedHealth (UNH) stake by 22% in Q2 2026, selling an estimated $90.4K and leaving 890 shares worth $370K. The position accounts for 0.03% of the portfolio, ranked #144.

Nixon Peabody Trust first reported a position in UNH in Q4 2021 and has held it in 17 quarters since. The position peaked at $637K in Q2 2024. 1,373 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • Nixon Peabody Trust held 890 shares of UnitedHealth worth $370K as of Q2 2026.
  • Nixon Peabody Trust sold 244 UnitedHealth shares in Q2 2026, an estimated $90.4K.
  • UnitedHealth made up 0.03% of Nixon Peabody Trust's portfolio in Q2 2026, its #144 holding.
  • Nixon Peabody Trust first reported a position in UnitedHealth in Q4 2021 and has held it in 17 quarters since.
  • Nixon Peabody Trust's UnitedHealth position peaked at $637K in Q2 2024.
  • 1,373 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on Nixon Peabody Trust's 13F filing for Q2 2026, filed 27 Jul 2026.